$EQBK
Equity Bancshares Inc Stock $eqbk

$eqbk Overview Financials Valuation SEC Filings Company Website

2020 Q3 Form 10-Q Financial Statement

#000156459020048927 Filed on October 29, 2020

Income Statement

Concept	2020 Q3	2019 Q3
Revenue	$37.08M	$44.55M
YoY Change	-16.76%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.000M	$1.700M
YoY Change	17.65%	13.33%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$4.975M	$13.02M
YoY Change	-61.8%	26.84%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$93.06M	$13.20M
YoY Change	-805.21%	-0.41%
Income Tax	-$2.650M	$2.790M
% Of Pretax Income		21.14%
Net Earnings	-$90.41M	$10.41M
YoY Change	-968.78%	0.81%
Net Earnings / Revenue	-243.8%	23.36%
Basic Earnings Per Share	-$6.01	$0.67
Diluted Earnings Per Share	-$6.01	$0.66
COMMON SHARES
Basic Shares Outstanding	15.04M	15.51M
Diluted Shares Outstanding	15.04M	15.71M

Balance Sheet

Concept	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$65.84M	$168.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$86.09M	$84.48M
YoY Change	1.9%	6.13%
Goodwill	$31.60M	$136.4M
YoY Change	-76.84%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$3.866B	$4.075B
YoY Change	-5.13%	3.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.00M	$13.90M
YoY Change	36.69%	14.88%
Accrued Expenses	$3.700M	$3.000M
YoY Change	23.33%
Deferred Revenue
YoY Change
Short-Term Debt	$46.30M	$40.70M
YoY Change	13.76%	-6.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$22.70M	$16.90M
YoY Change	34.32%	39.67%
LONG-TERM LIABILITIES
Long-Term Debt	$87.50M	$29.30M
YoY Change	198.63%	-24.09%
Other Long-Term Liabilities	$5.500M	$3.700M
YoY Change	48.65%	117.65%
Total Long-Term Liabilities	$93.00M	$33.00M
YoY Change	181.82%	-18.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.70M	$16.90M
Total Long-Term Liabilities	$93.00M	$33.00M
Total Liabilities	$3.463B	$3.608B
YoY Change	-4.0%	3.44%
SHAREHOLDERS EQUITY
Retained Earnings	$38.30M	$115.7M
YoY Change	-66.91%
Common Stock	$386.2M	$382.3M
YoY Change	1.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$43.35M	$30.52M
YoY Change	42.03%
Treasury Stock Shares
Shareholders Equity	$402.2M	$467.1M
YoY Change
Total Liabilities & Shareholders Equity	$3.866B	$4.075B
YoY Change	-5.13%	3.65%

Cashflow Statement

Concept	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	-$90.41M	$10.41M
YoY Change	-968.78%	0.81%
Depreciation, Depletion And Amortization	$2.000M	$1.700M
YoY Change	17.65%	13.33%
Cash From Operating Activities	$11.80M	$12.00M
YoY Change	-1.67%	-14.29%
INVESTING ACTIVITIES
Capital Expenditures	-$2.000M	-$400.0K
YoY Change	400.0%	-92.16%
Acquisitions
YoY Change
Other Investing Activities	$147.6M	$93.00M
YoY Change	58.71%	-259.25%
Cash From Investing Activities	$145.6M	$92.60M
YoY Change	57.24%	-245.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-269.9M	-117.9M
YoY Change	128.92%	-286.26%
NET CHANGE
Cash From Operating Activities	11.80M	12.00M
Cash From Investing Activities	145.6M	92.60M
Cash From Financing Activities	-269.9M	-117.9M
Net Change In Cash	-112.5M	-13.30M
YoY Change	745.86%	-196.38%
FREE CASH FLOW
Cash From Operating Activities	$11.80M	$12.00M
Capital Expenditures	-$2.000M	-$400.0K
Free Cash Flow	$13.80M	$12.40M
YoY Change	11.29%	-35.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P16Y7M6D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P16Y
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	0
CY2020Q3	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	9053000
CY2020Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	34087000
CY2020Q3	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	2691626000
CY2020Q3	us-gaap	Other Real Estate And Foreclosed Assets OtherRealEstateAndForeclosedAssets	8727000
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	86087000
CY2020Q3	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	76555000
CY2020Q3	us-gaap	Federal Home Loan Bank Stock And Federal Reserve Bank Stock FederalHomeLoanBankStockAndFederalReserveBankStock	32545000
CY2020Q3	us-gaap	Interest Receivable InterestReceivable	18110000
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	596000
	eqbk	Employee Stock Loans Repayments Value EmployeeStockLoansRepaymentsValue	34000
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	12827000
	us-gaap	Net Income Loss NetIncomeLoss	15565000
	us-gaap	Share Based Compensation ShareBasedCompensation	2349000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2637000
	eqbk	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	465000
	eqbk	Amortization Of Cloud Computing Implementation Costs AmortizationOfCloudComputingImplementationCosts	73000
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	3639000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4315000
	eqbk	Amortization Of Intangibles AmortizationOfIntangibles	2385000
	eqbk	Increase Decrease In Federal Home Loan Bank Stock Dividends IncreaseDecreaseInFederalHomeLoanBankStockDividends	-704000
	eqbk	Gain Loss On Sales And Valuation Adjustments On Other Real Estate Owned GainLossOnSalesAndValuationAdjustmentsOnOtherRealEstateOwned	143000
CY2020Q3	us-gaap	Goodwill Goodwill	31601000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17101000
CY2020Q3	us-gaap	Other Assets OtherAssets	29252000
CY2020Q3	us-gaap	Assets Assets	3865571000
CY2020Q3	us-gaap	Demand Deposit Accounts DemandDepositAccounts	693967000
CY2020Q3	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	693967000
CY2020Q3	us-gaap	Deposits Money Market Deposits And Negotiable Order Of Withdrawal Now DepositsMoneyMarketDepositsAndNegotiableOrderOfWithdrawalNOW	1816307000
CY2020Q3	us-gaap	Time Deposits TimeDeposits	623344000
CY2020Q3	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	2439651000
CY2020Q3	us-gaap	Deposits Deposits	3133618000
CY2020Q3	us-gaap	Federal Funds Purchased And Securities Sold Under Agreements To Repurchase FederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase	46295000
CY2020Q3	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	167862000
CY2019Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	8990000
CY2020Q3	us-gaap	Subordinated Debt SubordinatedDebt	87537000
CY2020Q3	us-gaap	Contractual Obligation ContractualObligation	5478000
CY2020Q3	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	22609000
CY2020Q3	us-gaap	Liabilities Liabilities	3463399000
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	174000
CY2020Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	386017000
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	38299000
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	21074000
CY2020Q3	eqbk	Loans Receivable To Purchase Of Common Stock For Terminating Employee Restricted Stock LoansReceivableToPurchaseOfCommonStockForTerminatingEmployeeRestrictedStock	43000
CY2020Q3	us-gaap	Treasury Stock Value TreasuryStockValue	43349000
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	402172000
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3865571000
CY2020Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	32278000
CY2020Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	37082000
CY2020Q3	us-gaap	Interest Expense Deposits InterestExpenseDeposits	3064000
	eqbk	Interest Expense Federal Reserve Bank Discount Window InterestExpenseFederalReserveBankDiscountWindow	6000
CY2019Q3	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	311000
CY2020Q3	us-gaap	Interest Expense InterestExpense	4975000
CY2019Q3	us-gaap	Interest Expense InterestExpense	13023000
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	32107000
CY2019Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	31526000
CY2020Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	815000
CY2019Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	679000
CY2020Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	31292000
CY2019Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	30847000
CY2020Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	489000
CY2019Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	507000
CY2019Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	4000
	us-gaap	Gain Loss On Investments GainLossOnInvestments	12000
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1697000
CY2020Q3	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	104831000
CY2019Q3	us-gaap	Professional Fees ProfessionalFees	991000
	us-gaap	Professional Fees ProfessionalFees	3187000
CY2019Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	806000
CY2019Q3	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	768000
	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	1929000
CY2019Q3	us-gaap	Noninterest Income NoninterestIncome	6572000
	us-gaap	Noninterest Income NoninterestIncome	17523000
CY2019Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	13039000
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	40076000
CY2019Q3	us-gaap	Occupancy Net OccupancyNet	2177000
	us-gaap	Occupancy Net OccupancyNet	6578000
CY2019Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	2673000
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	8243000
CY2019Q3	us-gaap	Communication Communication	523000
	us-gaap	Communication Communication	1363000
CY2019Q3	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	111000
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	1291000
CY2019Q3	us-gaap	Postage Expense PostageExpense	352000
	us-gaap	Postage Expense PostageExpense	1103000
CY2019Q3	eqbk	Free Nationwide Atm Cost FreeNationwideATMCost	459000
	eqbk	Free Nationwide Atm Cost FreeNationwideATMCost	1186000
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	784000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2806000
CY2019Q3	us-gaap	Loan Processing Fee LoanProcessingFee	165000
	us-gaap	Loan Processing Fee LoanProcessingFee	628000
CY2019Q3	us-gaap	Other Revenue Expense From Real Estate Operations OtherRevenueExpenseFromRealEstateOperations	88000
	us-gaap	Other Revenue Expense From Real Estate Operations OtherRevenueExpenseFromRealEstateOperations	-710000
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	11900000
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1215000
CY2020Q3	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod	240000
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	50762000
	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	264000
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	104831000
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	6831000
	us-gaap	Noninterest Expense NoninterestExpense	180530000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-89169000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1711000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-87458000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.75
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.75
	us-gaap	Net Income Loss NetIncomeLoss	-87458000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	2321000
CY2020Q3	us-gaap	Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax	24848000
	us-gaap	Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax OtherComprehensiveIncomeReclassificationAdjustmentForHeldToMaturityTransferredToAvailableForSaleSecuritiesBeforeTax	24848000
CY2020Q3	eqbk	Other Comprehensive Income Loss Amortization Of Net Unrealized Gain Loss On Transfers To Held To Maturity From Available For Sale Securities Before Tax OtherComprehensiveIncomeLossAmortizationOfNetUnrealizedGainLossOnTransfersToHeldToMaturityFromAvailableForSaleSecuritiesBeforeTax	620000
CY2020Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	23625000
CY2020Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	5941000
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	17684000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	10000
	eqbk	Gain Loss On Foreclosed Assets GainLossOnForeclosedAssets	-280000
	eqbk	Gain Loss On Foreclosed Assets GainLossOnForeclosedAssets	-11000
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-72721000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	10406000
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	868000
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	617000
CY2019Q3	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	1000
CY2019Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	405000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	479766000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-90405000
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	17684000
CY2020Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	242000
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	402172000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	455941000
	us-gaap	Net Income Loss NetIncomeLoss	15565000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4444000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2349000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	316000
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	1000
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	405000
	eqbk	Employee Stock Loans Repayments Value EmployeeStockLoansRepaymentsValue	44000
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	10867000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	478060000
	us-gaap	Net Income Loss NetIncomeLoss	-87458000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	21077000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2670000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	20000
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	402172000
	us-gaap	Net Income Loss NetIncomeLoss	-87458000
	us-gaap	Share Based Compensation ShareBasedCompensation	2670000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2780000
	eqbk	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	462000
	eqbk	Amortization Of Cloud Computing Implementation Costs AmortizationOfCloudComputingImplementationCosts	81000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	23255000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	17299000
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	104831000
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1627000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4406000
	eqbk	Amortization Of Intangibles AmortizationOfIntangibles	2843000
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-5015000
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-383000
	eqbk	Increase Decrease In Federal Home Loan Bank Stock Dividends IncreaseDecreaseInFederalHomeLoanBankStockDividends	-585000
	eqbk	Gain Loss On Sales And Valuation Adjustments On Other Real Estate Owned GainLossOnSalesAndValuationAdjustmentsOnOtherRealEstateOwned	-120000
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	12000
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	17000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1000
	us-gaap	Proceeds From Payments For In Interest Bearing Deposits In Banks ProceedsFromPaymentsForInInterestBearingDepositsInBanks	1999000
	us-gaap	Proceeds From Payments For In Interest Bearing Deposits In Banks ProceedsFromPaymentsForInInterestBearingDepositsInBanks	1494000
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	172154000
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	26499000
	eqbk	Payments To Acquire Other Real Estate1 PaymentsToAcquireOtherRealEstate1	62000
	eqbk	Payments To Acquire Other Real Estate1 PaymentsToAcquireOtherRealEstate1	56000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6388000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6020000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	16000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	10000
	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	1895000
	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	1405000
	eqbk	Originations Of Loans Held For Sale OriginationsOfLoansHeldForSale	87429000
	eqbk	Originations Of Loans Held For Sale OriginationsOfLoansHeldForSale	71483000
	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	85780000
	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	67076000
	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	1452000
	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	1494000
	us-gaap	Increase Decrease In Derivative Assets IncreaseDecreaseInDerivativeAssets	-411000
	us-gaap	Increase Decrease In Derivative Assets IncreaseDecreaseInDerivativeAssets	-502000
	us-gaap	Operating Lease Payments OperatingLeasePayments	544000
	us-gaap	Operating Lease Payments OperatingLeasePayments	583000
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	2371000
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-394000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5729000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3104000
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	2627000
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	760000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	36430000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	30866000
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	91495000
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	2754000
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	106019000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	73588000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	20096000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	156963000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	86565000
	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	1991000
	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	312000
	eqbk	Payments For Proceeds From Federal Home Loan Bank Stock And Federal Reserve Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStockAndFederalReserveBankStock	823000
	eqbk	Payments For Proceeds From Federal Home Loan Bank Stock And Federal Reserve Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStockAndFederalReserveBankStock	1792000
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	3947000
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	1331000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35172000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	54782000
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	70019000
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-115208000
	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	10587000
	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	-9416000
	eqbk	Proceeds From Repayments Of Federal Home Loan Bank Borrowings ProceedsFromRepaymentsOfFederalHomeLoanBankBorrowings	-157223000
	eqbk	Proceeds From Repayments Of Federal Home Loan Bank Borrowings ProceedsFromRepaymentsOfFederalHomeLoanBankBorrowings	27453000
	us-gaap	Proceeds From Federal Home Loan Bank Advances ProceedsFromFederalHomeLoanBankAdvances	253000000
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	252273000
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	2240000
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	62000000
	eqbk	Principal Payments On Federal Reserve Bank Discount Window PrincipalPaymentsOnFederalReserveBankDiscountWindow	62000000
	eqbk	Noncash Or Part Noncash Operating Leases Recognized NoncashOrPartNoncashOperatingLeasesRecognized	3546000
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Reclassifications</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Some items in prior financial statements were reclassified to conform to the current presentation. Management determined the items reclassified are immaterial to the consolidated financial statements taken as a whole and did not result in a change in equity or net income for the periods reported.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Risk and Uncertainties</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The outbreak of COVID-19 has adversely impacted a broad range of industries in which the Company’s customers operate and could impair their ability to fulfill their financial obligations to the Company. The World Health Organization has declared COVID-19 to be a global pandemic indicating that almost all public commerce and related business activities must be, to varying degrees, curtailed with the goal of decreasing the rate of new infections. The spread of the outbreak has caused significant disruptions in the U.S. economy and has disrupted banking and other financial activity in the areas in which the Company operates. While there has been no material impact to the Company’s employees to date, COVID-19 could also potentially create widespread business continuity issues for the Company.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Congress, the President, and the Federal Reserve have taken several actions designed to cushion the economic fallout. Most notably, the CARES Act was signed into law at the end of March 2020 as a $2 trillion legislative package. The goal of the CARES Act is to prevent a severe economic downturn through various measures, including direct financial aid to American families and economic stimulus to significantly impacted industry sectors. The package also includes extensive emergency funding for hospitals and medical providers. In addition to the general impact of COVID-19, certain provisions of the CARES Act as well as other recent legislative and regulatory relief efforts are expected to have a material impact on the Company’s operations.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s business is dependent upon the willingness and ability of its employees and customers to conduct banking and other financial transactions. If the global response to contain COVID-19 is unsuccessful, the Company could experience a material adverse effect on its business, financial condition, results of operations and cash flows. While it is not possible to know the full universe or extent that the impact of COVID-19, and resulting measures to curtail its spread, will have on the Company’s operations, the Company is disclosing potentially material items of which it is aware.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Financial position and results of operations</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s interest income and fees could be reduced due to COVID-19. In keeping with guidance from regulators, the Company is actively working with COVID-19 affected borrowers to defer their payments, interest, and fees. While interest and fees will still accrue to income, through normal GAAP accounting, should eventual credit losses on these deferred payments emerge, interest income and fees accrued would need to be reversed. In such a scenario, interest income in future periods could be negatively impacted. At this time, the Company is unable to project the materiality of such an impact but recognizes the breadth of the economic impact may affect its borrowers’ ability to repay in future periods.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Capital and liquidity</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of September 30, 2020, all our capital ratios, and our subsidiary bank’s capital ratios, were in excess of regulatory requirements. While we are currently classified as well capitalized, an extended economic recession brought about by COVID-19 could adversely impact our reported and regulatory capital ratios by further credit losses. The Company relies on cash on hand as well as dividends from its subsidiary bank to service its debt. If the Company’s subsidiary bank’s capital deteriorates such that it is unable to pay dividends to the Company for an extended period of time, the Company may not be able to service its debt.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains access to multiple sources of liquidity. Wholesale funding markets have remained open to us, but rates for short term funding have historically been volatile. If funding costs are elevated for an extended period of time, it could have an adverse effect on the Company’s net interest margin. If an extended recession caused large numbers of the Company’s deposit customers to withdraw their funds, the Company might become more reliant on volatile or more expensive sources of funding.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Asset valuation</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Currently, the Company does not expect COVID-19 to affect its ability to account timely for the assets on its balance sheet; however, this could change in future periods. While certain valuation assumptions and judgments will change to account for pandemic-related circumstances such as widening credit spreads, the Company does not anticipate significant changes in methodology used to determine the fair value of assets measured in accordance with GAAP.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At September 30, 2020, the Company performed a quantitative analysis to assess goodwill for impairment of Equity Bancshares, Inc., the sole reporting unit. Consideration was given to the on-going economic market disruption, the movement of the Company’s stock price in relation to other bank indexes and the length of time that the market value of the reporting unit has been below its book value as triggering events and completed a quantitative analysis to assess whether or not goodwill was impaired. This analysis determined that goodwill was impaired and subsequently the Company booked a non-cash impairment charge of $104,831 to goodwill on September 30, 2020. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The determination of the fair value of the reporting unit incorporates assumptions that marketplace participants would use in their estimates of fair value in a change in control transaction, as prescribed by ASC Topic 820. To arrive at a conclusion of fair value, we utilized both the income approach and the market approach and then applied weighting factors to each approach. Weighting factors represent our best business judgement of the weightings a market participant would utilize in arriving at fair value of the reporting unit. In performing the analysis, Company management made numerous assumptions with respect to industry performance, reporting unit business performance, economic and market conditions and various other matters, many of which require significant management judgement. Projections related to business unit performance over the next five years assumed an economic downturn over a 12-month time horizon subsequently returning to conservative positive growth rates in loan and deposits after that time period. The analysis performed and the assumptions that are incorporated into the analysis reflect the best currently available estimates and judgements as to the expected future financial performance of the reporting unit. At September 30, 2020, the Company had goodwill of $31,601 which could be at risk of further impairment with further declines in performance, stock price or market conditions for bank stocks.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Processes, controls and business continuity plan</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of September 30, 2020, all the Company’s bank locations were open to customers with social distancing measures in place, allowing full access for customer use. Customers are served by appointment, calling ahead, curbside and drive-through but offered full lobby access during normal hours. The Company does not anticipate incurring additional material cost related to its continued deployment of the preparedness plan and no material operational or internal control challenges or risks have been identified to date. The Company does not anticipate significant challenges to its ability to maintain its systems and controls in light of the measures the Company has taken to prevent the spread of COVID-19. The Company has not experienced any material resource constraints through the implementation of its business continuity plans.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Lending operations and accommodations to borrowers</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In keeping with regulatory guidance to work with borrowers during this unprecedented situation and as outlined in the CARES Act, the Company has worked with customers affected by COVID-19 and offered short-term assistance in accordance with regulatory guidelines. Commercial borrowers needing assistance have been offered either a 90-day principal and interest deferral or a 180-day principal only deferral. Commercial borrowers that originally requested a 90-day deferral can request an additional 90-day deferral by providing their previous year financial information, current year interim financial information, projections for the balance of the calendar year and information related to their cash reserves to show a need for the additional 90-day deferral. Consumers needing assistance have been offered a 90-day principal and interest deferral with an option to request an additional 90-day deferral. At the end of the deferral period, the interest will be capitalized and the loan re-amortized generally causing a minimal increase to payments for most consumers. As of September 30, 2020, the Company had 68 remaining deferrals on outstanding loan balances of $41,228, with interest deferred of $306. In accordance with interagency guidance issued in March 2020, these short-term deferrals are not automatically considered troubled debt restructurings, are not reflected in past due loan balances and have not been reported as a classified loan solely due to a deferral. These deferred loans are subject to ongoing monitoring and will be downgraded or placed on nonaccrual if a noted weakness exists.</p> <p style="margin-bottom:6pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table lists loans by category that have been deferred under the payment deferral program at September 30, 2020.</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial real estate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,965</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial and industrial</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,746</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Residential real estate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,752</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agricultural real estate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">643</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consumer</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total loans</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,228</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With the passage of the Paycheck Protection Program (“PPP”), administered by the Small Business Administration (“SBA”), the Company actively participated in assisting its customers with applications for resources through the program. PPP loans originated prior to June 5, 2020, have a <span style="-sec-ix-hidden:F_000637">two-year</span> term and originated on or after June 5, 2020, have a <span style="-sec-ix-hidden:F_000638">five-year</span> term, unless the lender and borrower agree differently. All PPP loans earn interest at 1.0%. As of September 30, 2020, there were 3,221 loans with an outstanding balance of $367,844 that were originated under the PPP program. It is the Company’s understanding that loans funded through the PPP program are fully guaranteed by the U.S. government. Should those circumstances change, the Company could be required to establish additional allowance for loan loss through additional provision for loan loss expense charged to earnings.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Credit</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the current economic environment caused by the COVID-19 virus, the Company is engaging in frequent communication with borrowers to better understand their situation and the challenges faced, allowing the Company to respond proactively as needs and issues arise. Should economic conditions worsen, the Company could experience further increases in its required allowance for loan losses and record additional provision for loan losses. It is possible that the Company’s asset quality measures could worsen at future measurement periods if the effects of COVID-19 are prolonged.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Many industries have and will continue to experience adverse impacts as a result of COVID-19. Our exposure from outstanding loans and commitments to industries which we consider a higher risk totaled approximately $285,943 in hospitality and $65,088 in aircraft manufacturing.</p>
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	104831000
CY2020Q3	us-gaap	Goodwill Goodwill	31601000
CY2020Q3	eqbk	Cares Act Financing Receivable Modifications Number Of Contracts CARESActFinancingReceivableModificationsNumberOfContracts	68
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	38354000
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	7208000
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	47344000
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	7888000
	eqbk	Principal Receivables On Employee Stock Loan PrincipalReceivablesOnEmployeeStockLoan	34000
	eqbk	Principal Receivables On Employee Stock Loan PrincipalReceivablesOnEmployeeStockLoan	44000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	20000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	317000
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	596000
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	405000
	us-gaap	Proceeds From Issuance Of Subordinated Long Term Debt ProceedsFromIssuanceOfSubordinatedLongTermDebt	75000000
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2295000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	12827000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	10867000
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-358000
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-221000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24710000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-110413000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-23452000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-24765000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	89291000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	192818000
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	65839000
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	168053000
	us-gaap	Interest Paid Net InterestPaidNet	19730000
	us-gaap	Interest Paid Net InterestPaidNet	37536000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2208000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1786000
	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	2456000
	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	906000
	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	1982000
CY2020Q3	eqbk	Cares Act Financing Receivable Loan Modifications CARESActFinancingReceivableLoanModifications	41228
CY2020Q3	eqbk	Cares Act Payment Deferral Program Deferred Interest CaresActPaymentDeferralProgramDeferredInterest	306000
CY2020Q3	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	41228000
CY2020Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	293000
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	798576000
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	141082000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1261000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	276000
CY2019Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	769059000
CY2019Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	15414000
CY2019Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	562000
CY2019Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	783911000
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	8244000
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	8323000
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	27681000
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	28504000
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	64849000
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	66478000
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	88383000
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	90401000
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	581265000
CY2020Q3	us-gaap	Mortgage Backed Securities Available For Sale Fair Value Disclosure MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure	604870000
CY2020Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	770422000
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	798576000
CY2020Q3	us-gaap	Securities Held As Collateral At Fair Value SecuritiesHeldAsCollateralAtFairValue	717770000
CY2019Q4	us-gaap	Securities Held As Collateral At Fair Value SecuritiesHeldAsCollateralAtFairValue	780038000
CY2020Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	34012000
CY2020Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	24000
CY2020Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	34542000
CY2020Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	293000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	2017000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	32466000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	273000
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	34483000
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	276000
CY2019Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	28828000
CY2019Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	69000
CY2019Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	99340000
CY2019Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	661000
CY2019Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue	128168000
CY2019Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	730000
CY2020Q3	us-gaap	Held To Maturity Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions HeldToMaturitySecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions	38
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2556652000
CY2019Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	2544420000
CY2019Q4	eqbk	Unamortized Merger Purchase Accounting Adjustments Balance UnamortizedMergerPurchaseAccountingAdjustmentsBalance	8287000
CY2019Q4	eqbk	Loans Purchased At Discount LoansPurchasedAtDiscount	624747000
CY2020Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	34078000
CY2020Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	815000
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	69000
CY2020Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	34087000
CY2019Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	17777000
CY2019Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	679000
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12232000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	23255000
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	1827000
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	427000
CY2020Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	34087000
CY2018Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	11454000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	17299000
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	11888000
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	1010000
CY2019Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	17875000
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	7090000
CY2020Q3	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	24645000
CY2020Q3	eqbk	Allowance For Loan Losses Purchased Credit Impaired Loans AllowanceForLoanLossesPurchasedCreditImpairedLoans	2352000
CY2020Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	34087000
CY2020Q3	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	43679000
CY2020Q3	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	2662255000
CY2020Q3	eqbk	Financing Receivable Purchase Credit Impaired Loans FinancingReceivablePurchaseCreditImpairedLoans	19779000
CY2020Q3	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2725713000
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	935000
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	11017000
CY2019Q4	eqbk	Allowance For Loan Losses Purchased Credit Impaired Loans AllowanceForLoanLossesPurchasedCreditImpairedLoans	280000
CY2019Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	29551000
CY2019Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	2503711000
CY2019Q4	eqbk	Financing Receivable Purchase Credit Impaired Loans FinancingReceivablePurchaseCreditImpairedLoans	23390000
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2556652000
CY2020Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	24476000
CY2020Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	18092000
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	28323000
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	22839000
CY2020Q3	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	39290000
CY2020Q3	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	34653000
CY2020Q3	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	9442000
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	10388000
CY2020Q3	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	63766000
CY2020Q3	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	52745000
CY2020Q3	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	9442000
CY2019Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	40223000
CY2019Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	33227000
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1215000
CY2020Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	18137000
CY2019Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod	22000
CY2020Q3	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	32455000
CY2019Q3	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod	35000
CY2020Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	50592000
CY2020Q3	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	289000
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	19650000
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod	78000
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	15787000
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod	137000
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod	440000
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	34975000
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod	127000
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	43650000
	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	518000
CY2020Q3	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	248000
CY2020Q3	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	52745000
CY2020Q3	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	2667875000
CY2020Q3	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2725713000
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	38379000
CY2020Q3	us-gaap	Hedged Asset Fair Value Hedge HedgedAssetFairValueHedge	5640000
CY2020Q3	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	125655000
CY2020Q3	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	7937000
CY2020Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	9299000
CY2019Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	120368000
CY2019Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	3535000
CY2019Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	4076000
CY2020Q3	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	9401000
CY2019Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	4186000
CY2020Q3	eqbk	Derivative Asset Netting Adjustment DerivativeAssetNettingAdjustment	102000
CY2017Q1	eqbk	Debt Instrument Floating Floor Interest Rate DebtInstrumentFloatingFloorInterestRate	0.0350
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	2514239000
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2556652000
CY2020Q3	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2725713000
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2556652000
CY2020Q3	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	15045000
CY2019Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	15508000
CY2020Q3	eqbk	Financing Receivable Tdr Allowance FinancingReceivableTDRAllowance	367000
CY2019Q4	eqbk	Financing Receivable Tdr Allowance FinancingReceivableTDRAllowance	0
CY2020Q3	us-gaap	Loans And Leases Receivable Impaired Commitment To Lend LoansAndLeasesReceivableImpairedCommitmentToLend	0
CY2019Q4	us-gaap	Loans And Leases Receivable Impaired Commitment To Lend LoansAndLeasesReceivableImpairedCommitmentToLend	0
CY2020Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
CY2019	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0
CY2020	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0
	eqbk	Cares Act Financing Receivable Modifications Number Of Contracts CARESActFinancingReceivableModificationsNumberOfContracts	63
	eqbk	Cares Act Of2020 Aid Amount CARESActOf2020AidAmount	40232000
CY2020Q3	eqbk	Derivative Liability Netting Adjustment DerivativeLiabilityNettingAdjustment	102000
CY2019Q4	eqbk	Derivative Asset Netting Adjustment DerivativeAssetNettingAdjustment	182000
CY2019Q4	eqbk	Derivative Liability Netting Adjustment DerivativeLiabilityNettingAdjustment	182000
CY2020Q3	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	8039000
CY2019Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	3717000
CY2019Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	72000
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	185000
	us-gaap	Operating Lease Cost OperatingLeaseCost	549000
CY2020Q3	us-gaap	Hedged Asset Fair Value Hedge Cumulative Increase Decrease HedgedAssetFairValueHedgeCumulativeIncreaseDecrease	555000
CY2020Q3	us-gaap	Gain Loss On Fair Value Hedge Ineffectiveness Net GainLossOnFairValueHedgeIneffectivenessNet	0
CY2019Q3	us-gaap	Gain Loss On Fair Value Hedge Ineffectiveness Net GainLossOnFairValueHedgeIneffectivenessNet	0
	us-gaap	Gain Loss On Fair Value Hedge Ineffectiveness Net GainLossOnFairValueHedgeIneffectivenessNet	0
	us-gaap	Gain Loss On Fair Value Hedge Ineffectiveness Net GainLossOnFairValueHedgeIneffectivenessNet	0
CY2020Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	77000
CY2019Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-180000
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-407000
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-502000
CY2020Q3	eqbk	Gain Loss On Derivative Instruments And Hedging Activities Net Pretax GainLossOnDerivativeInstrumentsAndHedgingActivitiesNetPretax	77000
CY2019Q3	eqbk	Gain Loss On Derivative Instruments And Hedging Activities Net Pretax GainLossOnDerivativeInstrumentsAndHedgingActivitiesNetPretax	-180000
	eqbk	Gain Loss On Derivative Instruments And Hedging Activities Net Pretax GainLossOnDerivativeInstrumentsAndHedgingActivitiesNetPretax	-407000
	eqbk	Gain Loss On Derivative Instruments And Hedging Activities Net Pretax GainLossOnDerivativeInstrumentsAndHedgingActivitiesNetPretax	-502000
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3691000
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3655000
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0298
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4153000
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4112000
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0295
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	184000
	us-gaap	Operating Lease Cost OperatingLeaseCost	540000
CY2020Q3	us-gaap	Variable Lease Cost VariableLeaseCost	3000
CY2019Q3	us-gaap	Variable Lease Cost VariableLeaseCost	12000
	us-gaap	Variable Lease Cost VariableLeaseCost	22000
	us-gaap	Variable Lease Cost VariableLeaseCost	35000
CY2020Q3	us-gaap	Lease Cost LeaseCost	187000
CY2019Q3	us-gaap	Lease Cost LeaseCost	197000
	us-gaap	Lease Cost LeaseCost	571000
	us-gaap	Lease Cost LeaseCost	575000
	us-gaap	Lessor Sales Type Lease Lease Not Yet Commenced Description LessorSalesTypeLeaseLeaseNotYetCommencedDescription	There were no sales and leaseback transactions, leverage leases, lease transactions with related parties or leases that had not yet commenced during the three or nine-month periods ended September 30, 2020.
CY2017Q1	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	0.0020
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	492000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	504000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	434000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	240000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	216000
CY2020Q3	eqbk	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	2886000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4772000
CY2020Q3	eqbk	Lessee Operating Lease Liability Discounted Amount LesseeOperatingLeaseLiabilityDiscountedAmount	1117000
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3655000
CY2020Q3	us-gaap	Federal Funds Purchased FederalFundsPurchased	0
CY2019Q4	us-gaap	Federal Funds Purchased FederalFundsPurchased	0
CY2020Q3	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	46295000
CY2019Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	35708000
	eqbk	Securities Sold Under Agreements To Repurchase Average Balance Of Agreements Outstanding SecuritiesSoldUnderAgreementsToRepurchaseAverageBalanceOfAgreementsOutstanding	44548000
CY2019	eqbk	Securities Sold Under Agreements To Repurchase Average Balance Of Agreements Outstanding SecuritiesSoldUnderAgreementsToRepurchaseAverageBalanceOfAgreementsOutstanding	42459000
	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	53543000
CY2019	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	45575000
CY2020Q3	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.0021
CY2019Q4	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.0040
CY2020Q3	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	167862000
CY2019Q4	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	324373000
CY2019Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40000000
CY2019Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2020-05-15
	eqbk	Debt Instrument Extended Date DebtInstrumentExtendedDate	2020-08-15
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2021-08-15
CY2017Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2020Q3	us-gaap	Subordinated Long Term Debt SubordinatedLongTermDebt	14793000
CY2019Q4	us-gaap	Subordinated Long Term Debt SubordinatedLongTermDebt	14561000
CY2020Q3	us-gaap	Subordinated Debt SubordinatedDebt	87537000
CY2019Q4	us-gaap	Subordinated Debt SubordinatedDebt	14561000
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	205652000
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2357000
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2357000
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2107000
CY2020Q3	eqbk	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	1643000
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	95620000
CY2020Q3	us-gaap	Long Term Debt LongTermDebt	309736000
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15040407
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15514042
CY2020Q3	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	383523
CY2020Q3	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	15.48
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	21074000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3000
CY2020Q3	eqbk	Common Equity Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.065
CY2020Q3	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	8
CY2020Q3	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	10
CY2020Q3	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	5
CY2020Q3	eqbk	Capital Conservation Buffer Required For Capital Adequacy CapitalConservationBufferRequiredForCapitalAdequacy	0.025
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-90405000
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10406000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-87458000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	15565000
CY2020Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	15040386
CY2019Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	15513969
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	15210856
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	15677972
CY2020Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	21
CY2019Q3	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	73
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	1045
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	1584
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15211901
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15679556
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.01
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.67
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.75
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.99
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-90405000
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	10406000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-87458000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	15565000
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15040407
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15514042
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15211901
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15679556
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	16025
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15040407
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.01
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	32428
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	29486
CY2020Q3	eqbk	Dilutive Effect Of Shares Excluded From Dilutive Calculation Due To Net Loss DilutiveEffectOfSharesExcludedFromDilutiveCalculationDueToNetLoss	84847
	eqbk	Dilutive Effect Of Shares Excluded From Dilutive Calculation Due To Net Loss DilutiveEffectOfSharesExcludedFromDilutiveCalculationDueToNetLoss	128900
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	709320
CY2019Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	489221
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	589644
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	317719
	eqbk	Fair Value Assets And Liabilities Levels Transfers Amount FairValueAssetsAndLiabilitiesLevelsTransfersAmount	0
CY2019	eqbk	Fair Value Assets And Liabilities Levels Transfers Amount FairValueAssetsAndLiabilitiesLevelsTransfersAmount	0
CY2019Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1474000
CY2019Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	14500000

Files In Submission

Name	View Source	Status
0001564590-20-048927-index-headers.html	Edgar Link	pending
0001564590-20-048927-index.html	Edgar Link	pending
0001564590-20-048927.txt	Edgar Link	pending
0001564590-20-048927-xbrl.zip	Edgar Link	pending
eqbk-10q_20200930.htm	Edgar Link	pending
eqbk-10q_20200930_htm.xml	Edgar Link	completed
eqbk-20200930.xsd	Edgar Link	pending
eqbk-20200930_cal.xml	Edgar Link	unprocessable
eqbk-20200930_def.xml	Edgar Link	unprocessable
eqbk-20200930_lab.xml	Edgar Link	unprocessable
eqbk-20200930_pre.xml	Edgar Link	unprocessable
eqbk-ex311_8.htm	Edgar Link	pending
eqbk-ex312_7.htm	Edgar Link	pending
eqbk-ex321_9.htm	Edgar Link	pending
eqbk-ex322_6.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EQBK
Equity Bancshares Inc Stock $eqbk

2020 Q3 Form 10-Q Financial Statement

#000156459020048927 Filed on October 29, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EQBK Equity Bancshares Inc Stock $eqbk

2020 Q3 Form 10-Q Financial Statement

#000156459020048927 Filed on October 29, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EQBK
Equity Bancshares Inc Stock $eqbk